Dominican company based in Santo Domingo · We only ship within the Dominican Republic · No international shippingDominican Republic only · No international shipping
ES Home Catalog Education COAs Calculator Founder
5-Amino-1MQ
Renova Verification
  • ✓≥99% purity by HPLC + mass spectrometry
  • ✓Independent Janoshik 3rd-party analysis
  • ✓−20°C lyophilized · 2–8°C reconstituted
🧪 View COA →
Home › Products › Metabolic Research › 5-Amino-1MQ
← Back to catalog Metabolic ResearchAvailable

5-Amino-1MQ (50 mg)

MetabolismFat burningNNMT
$240 USD50 mg/vial
🧪 Bacteriostatic water — needed to reconstitute the lyophilized vial
💰 Buy by volume
3+ of one
Save 15%
5+ of one
Save 25%
★ Wholesale
10+ of one
Save 40%
🔀 Mix & Match · across different products: 3+ items 10% · 5+ 15% · 7+ 20%
The best discount per product is applied automatically at checkout (they don't stack). Excludes bacteriostatic water; Retatrutide and Tirzepatide only get same-product volume. Can't be combined with promo codes.
🧪 COA❄️ Cold chain🛡️ Replacement guarantee🔒 Secure payment📦 Nationwide shipping🇺🇸 cGMP · ISO 9001 guidelines · COA

Selective NNMT (nicotinamide N-methyltransferase) inhibitor — unlocks fat oxidation and improves cellular energy metabolism.

  • Mechanism: NNMT inhibitor (known target) that preserves NAD+ and unblocks lipid oxidation.
  • Evidence: Preclinical only (mice): reduced fat mass. No human trials.
  • In context: No human safety or efficacy data.
Rango de investigación · SC
Not administered SC
🔴 Research convention · oral molecule (capsule); SC not used

Ranges cited in research literature. Not a usage recommendation. For research use only.

📋 Technical datasheet · Compound specifications
Compound5-Amino-1MQ
Origin🇺🇸 From US-based suppliers that follow strict cGMP & ISO 9001 guidelines
FormLyophilized in sterile vial (or pre-mixed solution depending on SKU)
Molecular formulaC10H10N2
Molecular weight158.20 g/mol
Purity≥99% by HPLC + mass spectrometry (Janoshik Analytical)
StorageLyophilized: −20°C to −80°C, dry, dark · Reconstituted: 2–8°C · stability varies by peptide (see the reconstitution guide and the product COA)
Recommended solventBacteriostatic water (0.9% benzyl alcohol) or 0.9% saline
Cold chain2–8°C in transit · controlled thermal packaging
UseResearch Use Only (RUO). Not intended for human or veterinary use.

Typical values for this compound category. For product-specific data, see the corresponding COA at /en/coa/.

This product is exclusively for research purposes. Not intended for human use, consumption, or therapeutic applications. For laboratory use only under qualified supervision.

5-Amino-1MQ: research profile

5-Amino-1MQ (5-amino-1-methylquinolinium) is not a peptide: it is a small molecule, a 158-Da quinolinium cation designed at the University of Texas Medical Branch (Stanley Watowich's laboratory) as a selective inhibitor of the enzyme nicotinamide N-methyltransferase (NNMT). It is usually supplied as the iodide salt and, unlike the rest of the catalog, is administered orally in the literature.

NNMT consumes nicotinamide and S-adenosylmethionine to produce 1-methylnicotinamide; when overexpressed in adipose tissue it drains precursors of NAD+ and of the methylation cycle. By inhibiting it, 5-Amino-1MQ raises intracellular NAD+ and SAM, which in cultured adipocytes and in mice on a high-fat diet translated into less lipid accumulation, smaller adipocytes and higher energy expenditure (Neelakantan et al., Biochemical Pharmacology 2018). NNMT is also investigated in cancer, liver fibrosis and muscle aging.

All available evidence is preclinical: cells and rodents. There are no published clinical trials in humans on safety or efficacy, and the molecule has no regulatory status as a drug in any country. It is a laboratory reagent with a well-defined molecular target, which makes it useful for studying the NNMT–NAD+ axis, but any extrapolation to humans is unsupported. Renova distributes it strictly for research use.

5-Amino-1MQ technical data

ClassSmall molecule (non-peptide) · selective NNMT inhibitor
Chemical name5-amino-1-methylquinolinium (usually as iodide)
CAS42464-96-0
TargetNicotinamide N-methyltransferase (NNMT), low-micromolar IC50
Route in the literatureOral (murine models); not administered subcutaneously
StatusPreclinical; no human trials, no regulatory approval
SolubilitySoluble in water and DMSO; protect from light

Questions about 5-Amino-1MQ

Is 5-Amino-1MQ a peptide?

No. It is a small molecule of the quinolinium family, only 158 Da, with no amino acids. It is in the catalog for its metabolic target (NNMT), not its structure, and it is the only catalog compound administered orally in the literature.

What does the NNMT enzyme do and why inhibit it?

NNMT methylates nicotinamide, spending NAD+ precursors and S-adenosylmethionine in the process. It is overexpressed in adipose tissue in obesity models and in several tumors. Inhibiting it raises intracellular NAD+ and reduces lipid accumulation in adipocytes, according to cell and mouse studies.

Are there human studies of 5-Amino-1MQ?

No clinical trials have been published. Available data come from cultured adipocytes and from mice on a high-fat diet (University of Texas Medical Branch, 2018). Human safety and efficacy are uncharacterized.

How does 5-Amino-1MQ relate to the NAD+ in the catalog?

They are two approaches to the same pathway: NAD+ supplies the coenzyme directly, while 5-Amino-1MQ blocks an enzyme that consumes its precursors. The literature studies them separately; there are no studies of the combination.

Related reading: 5-Amino-1MQ: NNMT Inhibitor · NAD+: The Coenzyme of Cellular Energy and Longevity

Informational content based on published scientific literature; it is not a recommendation for use or medical advice. Product strictly for research use (RUO), not suitable for human or veterinary consumption.

Questions? Write us

Your Order

Your cart is empty